Class information for:
Level 1: COXIBS//SOLUMATRIX//ROFECOXIB

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
11362 987 41.0 84%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
275 3       NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 43399
466 2             NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS 15930
11362 1                   COXIBS//SOLUMATRIX//ROFECOXIB 987

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 COXIBS authKW 278960 4% 21% 43
2 SOLUMATRIX authKW 250580 1% 90% 9
3 ROFECOXIB authKW 140121 4% 11% 43
4 NSAIDS authKW 127633 12% 3% 120
5 CYCLOOXYGENASE 2 INHIBITORS authKW 115209 2% 16% 23
6 COX 2 INHIBITORS authKW 113049 5% 8% 48
7 NON STEROIDAL ANTI INFLAMMATORY DRUGS authKW 99481 10% 3% 99
8 CARDIOVASCULAR THROMBOSIS authKW 61872 0% 100% 2
9 CEREBROVASCULAR RISKS authKW 61872 0% 100% 2
10 EUPENN GRP INVESTIGATORS address 61872 0% 100% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Cardiac & Cardiovascular System 2635 21% 0% 208
2 Peripheral Vascular Diseases 2510 15% 0% 151
3 Pharmacology & Pharmacy 2251 29% 0% 288
4 Rheumatology 1848 8% 0% 80
5 Medicine, General & Internal 1585 20% 0% 193
6 Hematology 97 4% 0% 38
7 Medicine, Research & Experimental 85 5% 0% 46
8 Public, Environmental & Occupational Health 62 5% 0% 46
9 Primary Health Care 37 1% 0% 7
10 Toxicology 29 2% 0% 24

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 EUPENN GRP INVESTIGATORS 61872 0% 100% 2
2 MED RHU 61872 0% 100% 2
3 NAVY YARD CORP 61872 0% 100% 2
4 TRANSLAT MED THER EUT 35825 3% 4% 28
5 ANAL MORFOQUANTITAT IMUNOHISTOQUIM 30936 0% 100% 1
6 ANESTHESIA INTENS CARE PAIN MED UNIT 30936 0% 100% 1
7 ANESTHESIA POSTOPERAT 30936 0% 100% 1
8 ATHEROSCLEROSIS UNIT MOL MED PHARMACOL 30936 0% 100% 1
9 CARDIAC NEUROL DIS 30936 0% 100% 1
10 CATEDRA MAGISTER TROMBOSIS 30936 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 7051 2% 1% 23
2 DRUG SAFETY 2883 1% 1% 14
3 CIRCULATION 2522 5% 0% 45
4 EXPERT OPINION ON DRUG SAFETY 1897 1% 1% 8
5 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS 1889 1% 1% 6
6 PLOS CLINICAL TRIALS 1603 0% 3% 2
7 ARCHIVES OF INTERNAL MEDICINE 1057 2% 0% 18
8 CLINICAL THERAPEUTICS 1033 1% 0% 13
9 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 833 2% 0% 15
10 CURRENT MEDICAL RESEARCH AND OPINION 821 1% 0% 11

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 COXIBS 278960 4% 21% 43 Search COXIBS Search COXIBS
2 SOLUMATRIX 250580 1% 90% 9 Search SOLUMATRIX Search SOLUMATRIX
3 ROFECOXIB 140121 4% 11% 43 Search ROFECOXIB Search ROFECOXIB
4 NSAIDS 127633 12% 3% 120 Search NSAIDS Search NSAIDS
5 CYCLOOXYGENASE 2 INHIBITORS 115209 2% 16% 23 Search CYCLOOXYGENASE+2+INHIBITORS Search CYCLOOXYGENASE+2+INHIBITORS
6 COX 2 INHIBITORS 113049 5% 8% 48 Search COX+2+INHIBITORS Search COX+2+INHIBITORS
7 NON STEROIDAL ANTI INFLAMMATORY DRUGS 99481 10% 3% 99 Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS Search NON+STEROIDAL+ANTI+INFLAMMATORY+DRUGS
8 CARDIOVASCULAR THROMBOSIS 61872 0% 100% 2 Search CARDIOVASCULAR+THROMBOSIS Search CARDIOVASCULAR+THROMBOSIS
9 CEREBROVASCULAR RISKS 61872 0% 100% 2 Search CEREBROVASCULAR+RISKS Search CEREBROVASCULAR+RISKS
10 CELECOXIB 59269 5% 4% 52 Search CELECOXIB Search CELECOXIB

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 PAPAGEORGIOU, N , ZACHARIA, E , BRIASOULIS, A , CHARAKIDA, M , TOUSOULIS, D , (2016) CELECOXIB FOR THE TREATMENT OF ATHEROSCLEROSIS.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 25. ISSUE 5. P. 619 -633 64 70% 0
2 MCGETTIGAN, P , HENRY, D , (2006) CARDIOVASCULAR RISK AND INHIBITION OF CYCLOOXYGENASE - A SYSTEMATIC REVIEW OF THE OBSERVATIONAL STUDIES OF SELECTIVE AND NONSELECTIVE INHIBITORS OF CYCLOOXYGENASE.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 296. ISSUE 13. P. 1633 -1644 33 92% 570
3 SINGH, BK , HAQUE, SE , PILLAI, KK , (2014) ASSESSMENT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED CARDIOTOXICITY.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 10. ISSUE 2. P. 143-156 61 70% 5
4 SHAU, WY , CHEN, HC , CHEN, ST , CHOU, HW , CHANG, CH , KUO, CW , LAI, MS , (2012) RISK OF NEW ACUTE MYOCARDIAL INFARCTION HOSPITALIZATION ASSOCIATED WITH USE OF ORAL AND PARENTERAL NON-STEROIDAL ANTI-INFLAMMATION DRUGS (NSAIDS): A CASE-CROSSOVER STUDY OF TAIWAN'S NATIONAL HEALTH INSURANCE CLAIMS DATABASE AND REVIEW OF CURRENT EVIDENCE.BMC CARDIOVASCULAR DISORDERS. VOL. 12. ISSUE . P. - 50 82% 19
5 OLSEN, AMS , FOSBOL, EL , GISLASON, GH , (2014) THE IMPACT OF NSAID TREATMENT ON CARDIOVASCULAR RISK - INSIGHT FROM DANISH OBSERVATIONAL DATA.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 115. ISSUE 2. P. 179 -184 41 89% 6
6 SCHMIDT, M , LAMBERTS, M , OLSEN, AMS , FOSBOLL, E , NIESSNER, A , TAMARGO, J , ROSANO, G , AGEWALL, S , KASKI, JC , KJELDSEN, K , ET AL (2016) CARDIOVASCULAR SAFETY OF NON-ASPIRIN NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: REVIEW AND POSITION PAPER BY THE WORKING GROUP FOR CARDIOVASCULAR PHARMACOTHERAPY OF THE EUROPEAN SOCIETY OF CARDIOLOGY.EUROPEAN HEART JOURNAL. VOL. 37. ISSUE 13. P. 1015 -U26 47 66% 2
7 STRAND, V , (2007) ARE COX-2 INHIBITORS PREFERABLE TO NON-SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH RISK OF CARDIOVASCULAR EVENTS TAKING LOW-DOSE ASPIRIN?.LANCET. VOL. 370. ISSUE 9605. P. 2138 -2151 59 64% 68
8 MOORE, N , SALVO, F , DUONG, M , BLIN, P , PARIENTE, A , (2014) CARDIOVASCULAR RISKS ASSOCIATED WITH LOW-DOSE IBUPROFEN AND DICLOFENAC AS USED OTC.EXPERT OPINION ON DRUG SAFETY. VOL. 13. ISSUE 2. P. 167 -179 56 55% 10
9 VARAS-LORENZO, C , RIERA-GUARDIA, N , CALINGAERT, B , CASTELLSAGUE, J , SALVO, F , NICOTRA, F , STURKENBOOM, M , PEREZ-GUTTHANN, S , (2013) MYOCARDIAL INFARCTION AND INDIVIDUAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS META-ANALYSIS OF OBSERVATIONAL STUDIES.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 22. ISSUE 6. P. 559-570 36 80% 33
10 BRESALIER, RS , SANDLER, RS , QUAN, H , BOLOGNESE, JA , OXENIUS, B , HORGAN, K , LINES, C , RIDDELL, R , MORTON, D , LANAS, A , ET AL (2005) CARDIOVASCULAR EVENTS ASSOCIATED WITH ROFECOXIB IN A COLORECTAL ADENOMA CHEMOPREVENTION TRIAL.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 352. ISSUE 11. P. 1092-1102 21 81% 1480

Classes with closest relation at Level 1


Rank Class id link
1 21642 GEORGE M OBRIEN KIDNEY UROL DIS//GEORGE OBRIEN KIDNEY UROL DIS//MACULA DENSA
2 1326 NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//LOW DOSE ASPIRIN
3 19756 MPGES 1//PROSTAGLANDIN E SYNTHASE//MPGES 1 INHIBITORS
4 2243 CYCLOOXYGENASE//PROSTAGLANDIN H SYNTHASE//AB HANCOCK JR MEM CANC
5 20784 NIMESULIDE//CAS 51803 78 2//AULINR
6 34596 CYCLOOXYGENASE 1 INHIBITOR//ANTIOXIDANT DEFENSE MECHANISM//BIOMED NETWORK HEPAT DIGEST DIS
7 5185 ASPIRIN RESISTANCE//ASPIRIN//PFA 100
8 23913 PTGS2//CYCLOOXYGENASE 2 GENE//COX 2 POLYMORPHISM
9 21370 NO NSAIDS//NCX 4016//NO ASPIRIN
10 20881 ENDOTHELIUM DEPENDENT CONTRACTION//ENDOTHELIUM DERIVED CONTRACTING FACTOR//THROMBOXANE PROSTANOID RECEPTOR

Go to start page